Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CDC25A | P30304 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25857265 | 0.86 | SMN1; SMN2 (0.46) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL65991 | 0.84 | FABP3 (0.39) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL13619233 | 0.84 | FABP3 (0.39) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL260180 | 0.82 | FABP3 (0.43) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL10029194 | 0.81 | BTN3A1 (0.36) | BLMTSHRBTN3A1 | |
| SCHEMBL8598240 | 0.81 | FABP3 (0.37) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL13745842 | 0.80 | FABP3 (0.43) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL27333212 | 0.80 | FABP3 (0.39) | FABP3SMN1; SMN2ADRA1ALMNAESR1 | |
| SCHEMBL18341416 | 0.79 | BTN3A1 (0.41) | TSHRBTN3A1 | |
| SCHEMBL13619237 | 0.79 | LMNA (0.58) | FABP3SMN1; SMN2ADRA1ALMNAESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020100090-A1 | CONTACT LENS WITH PHOSPHORYLCHOLINE-MODIFIED POLYVINYLALCOHOLS THEREIN | ALCON INC. (CH) | 2020-05-22 | — | — | WO | disclosed |
| EP-1577360-B1 | METHOD OF MODIFYING SURFACE OF MATERIAL | SHISEIDO CO LTD (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-20160367910-A1 | PACKING MATERIAL FOR HYDROPHILIC INTERACTION CHROMATOGRAPHY | SHISEIDO COMPANY, LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-8551332-B2 | Affinity particle and affinity separation method | SHISEIDO COMPANY, LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-8426627-B2 | Phosphorylcholine group-containing compound and surface modifying agent composed of such compound | SHISEIDO COMPANY, LTD. (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8277834-B2 | Method for producing protein adsorption-preventing ocular lens material | SHISEIDO COMPANY, LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8269031-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-09-18 | — | — | US | disclosed |
| US-20120205316-A1 | Packing Material For Hydrophilic Interaction Chromatography | SHISEIDO COMPANY, LTD. (JP) | 2012-08-16 | — | — | US | disclosed |
| US-8236873-B2 | Method of manufacturing protein adsorption preventing eye lens material | SHISEIDO CO., LTD. (JP) | 2012-08-07 | — | — | US | disclosed |
| US-8222442-B2 | Phosphorylcholine group-containing compound, method of manufacturing a phosphorylcholine group-containing compound, surface-modifying agent, and a method of modifying a surface using a surface-modifying agent | SHISEIDO COMPANY, LTD. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20090321357-A1 | Affinity Particle And Affinity Separation Method | SHISEIDO COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090156741-A1 | Protein Adsorption Prevention Eye Lens Material And Method For Producing Same | Ishihara, Kazuhiko (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20080300375-A1 | Ocular Lens Material and Method for Producing Same | ISHIHARA, KAZUHIKO (10% OWNERSHIP) (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080300375-A1 | Ocular Lens Material and Method for Producing Same | ISHIHARA, KAZUHIKO (10% OWNERSHIP) (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080214855-A1 | Phosphorylcholine Group Containing Compound and Surface Modifying Agent Composed of Such Compound | SHISEIDO CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20080038221-A1 | Method For Producing Protein Adsorption-Preventing Ocular Lens Material | SHISEIDO COMPANY, LTD. (JP) | 2008-02-14 | — | — | US | disclosed |
| EP-1818335-A1 | PHOSPHORYLCHOLINE GROUP-CONTAINING COMPOUND AND METHOD FOR PRODUCING SAME | Shiseido Company, Limited (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-20070181503-A1 | Affinity particle and affinity separation method | SHISEIDO COMPANY, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1750158-A1 | OCULAR LENS MATERIAL AND METHOD FOR PRODUCING SAME | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
| EP-1750160-A1 | METHOD FOR PRODUCING PROTEIN ADSORPTION-PREVENTING OCULAR LENS MATERIAL | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214855-A1 | Phosphorylcholine Group Containing Compound and Surface Modifying Agent Composed of Such Compound | PHOSPHO1, SGMS1, CHRM1 | FABP3 4196/4885SMN1; SMN2 3299/4885ADRA1A 1032/4885 |
| US-20090321357-A1 | Affinity Particle And Affinity Separation Method | FCGR1A, ACP1, FCGR3B | FABP3 312/4885SMN1; SMN2 4013/4885ADRA1A 964/4885 |
| US-20080038221-A1 | Method For Producing Protein Adsorption-Preventing Ocular Lens Material | PCTP, CRYAA, PHOSPHO1 | FABP3 593/4885SMN1; SMN2 4789/4885ADRA1A 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.